The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.
Receive the latest news on hepatitis treatments, clinical trials, social issues and important breakthroughs.
We value your privacy. We will not rent your email to anyone.
Interferon, Roferon A
Interferon Alfa 2b recombinant
Sequential Versus Concomitant Administration of Ribavirin and Interferon Alfa-n3 in Patients With Chronic Hepatitis C Not Responding to Interferon Alone: Results of a Randomized, Controlled Trial
Treatment of chronic viral hepatitis Quadrennial review
International Conference Reporter from 11th World Congress of Gastroenterology
Prospective Study of Interferon Therapy for Compensated Cirrhotic Patients With Chronic Hepatitis C by Monitoring Serum Hepatitis C RNA
Interferon, Ribavirin and Actigall
Interferon and the contribution of prolonged treatment in CHCV
Relationship of the Genomic Complexity of Hepatitis C Virus With Liver Disease Severity and Response to Interferon in Patients Wiith Chronic HCV Genotype 1b Interferon
Side effects in patients who discontinue Interferon
Interferon Side Effects
Interferon-alpha therapy may induce insulin
Long term efficacy of Ribavirin plus interferon alfa
NIH Interferon Alpha Trials
IFN Alfa-2b Plus Ribavirin Combination Increases Sustained Response Rate
Neurovisual Impairment: A Frequent Complication of Alpha-Interferon Treatment in Chronic Viral Hepatitis
Interferon-induced vitiligo in a patient with chronic viral hepatitis C infection
Key Interaction for Interferon Resistance in Hepatitis C Virus Discovered
Clinical Value of Grading and Staging Scores For Predicting A Long-term Response And Evaluating the Efficacy Of IFN Therapy
Complete eradication of hepatitis C virus after interferon treatment for chronic hepatitis C
Clinical significance of hepatic HCV RNA in patients with chronic hepatitis C demonstrating long-term sustained response to interferon-alpha therapy
Inside you'll discover:
You'll also receive the latest news and information to support liver health. Rest assured, we will not rent your email to anyone.
We will not rent/sell your email to anyone. You'll also receive our newsletter and special offers to support liver health.
You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.